[The efficacy of alteplase in pulmonary embolism treatment].

The results of pulmonary embolism treatment with streptase in 76 patients are discussed. All patients had submassive or massive pulmonary embolism. 66 (86%) of patients recovered. Thrombolysis with the use of heparin was performed in 9 patients, death occurred in 5 of them. Of 20 patients treated with "Actilize", death was reported in three cases. Authors consider alteplase to be highly effective in the treatment of massive pulmonary embolism. In case of late diagnostics of pulmonary embolism, especially recurrent, thrombolytic therapy remains to be effective up to 2 weeks after primary embolization.
AuthorsN N Malinovskiĭ, A K Gruzdev, L M Beskaeva, D V Sal' nikov, K Iu Nikerov, A S Abramov, I N Fineshin
JournalKhirurgiia (Khirurgiia (Mosk)) Issue 7 Pg. 4-7 ( 2008) ISSN: 0023-1207 [Print] Russia (Federation)
PMID18833155 (Publication Type: Comparative Study, English Abstract, Evaluation Studies, Journal Article)
Chemical References
  • Fibrinolytic Agents
  • Platelet Aggregation Inhibitors
  • Heparin
  • Streptokinase
  • Tissue Plasminogen Activator
  • Aspirin
  • Adult
  • Aged
  • Aged, 80 and over
  • Angiography
  • Aspirin (administration & dosage, therapeutic use)
  • Female
  • Fibrinolytic Agents (administration & dosage, therapeutic use)
  • Heparin (administration & dosage, therapeutic use)
  • Humans
  • Male
  • Middle Aged
  • Platelet Aggregation Inhibitors (administration & dosage, therapeutic use)
  • Pulmonary Embolism (diagnosis, drug therapy, mortality, radiography)
  • Streptokinase (administration & dosage, therapeutic use)
  • Time Factors
  • Tissue Plasminogen Activator (administration & dosage, therapeutic use)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: